Cover Image
Market Research Report

Plant-based Vaccines Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

Published by Coherent Market Insights Product code 769555
Published Content info 128 Pages
Delivery time: 2-3 business days
Price
Back to Top
Plant-based Vaccines Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026
Published: December 31, 2018 Content info: 128 Pages
Description

Report Description

Plants are a cost-effective, safe, and efficacious platform for large-scale production of vaccine in emerging economies and have the potential via oral administration to elicit a mucosal immune response. Key players in the market are focused on Research & Development (R&D) activities for development of plant-based vaccines for the treatment of infectious diseases. This is owing to the ability of plant-based vaccines to be mass produced, with higher efficiency, while maintaining lower cost compared to conventional vaccines.

Furthermore, increasing prevalence of infectious diseases is expected to drive growth of the plant-based vaccines market. For instance, according to World Health Organization (WHO) December 2017 estimate, a seasonal influenza may result in 290,000- 650,000 deaths each year owing to respiratory diseases alone.

Plants as a vaccine source have the ability to generate complex recombinant proteins with desired structures, while maintaining biological functions and offering greater immune-specificity. Plants can be used as potential delivery system for oral vaccines. These factors propel demand for plant-based vaccines. Moreover, successful completion of ongoing clinical trials studies in the future, is expected to offer lucrative opportunity to manufacturers thus, driving growth of the plant-based vaccines market. For instance, according to clinicalTrials: September 2015 update, clinical study evaluating a safety, tolerability and immunogenicity of a plant-made seasonal Quadrivalent VLP influenza vaccine in adults is currently in phase II clinical stage.

Market Dynamics

Higher efficiency of plant-based vaccines over conventional vaccines and R&D activities and clinical trials for the development plant-based are some of the factors expected to boost growth of the market. Plant-based vaccines against HIV have gained significant traction of researchers, since AIDS has evolved as an alarming health problem, which is increasing economic burden of African countries and several emerging economies. According to the The Joint United Nations Programme on HIV/AIDS (UNAIDS); in 2017, Eastern Europe, Central Asia, the Middle East and North Africa accounted for 95% of new HIV infections. Easy production, oral administration of plant-based vaccines, and absence of purification needs offer great advantage in designing plant-based viral vaccines.

Oral vaccines using plant-based formulations are considered as an alternative or may supplement for standard injection vaccines in the Hepatitis B (HBV) treatment, owing to low-cost production and easy vaccination. However, low efficiency and oral-tolerance are the main barrier in the production of plant-based anti-HBV vaccines. Moreover, according to a report published in the International Journal of Molecular Sciences, January 2013, in order to increase the efficiency of HBV antigen expression, intravenous injection of vaccine is required, as plant-produced purified HBV antigens are highly immunogenic when injected.

Key features of the study:

  • This report provides in-depth analysis of the global plant-based vaccines market, its market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2020 - 2026), considering 2021, as the base year.
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launch or approval, ongoing research and development activities, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global plant-based vaccines market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include, Medicago, Inc., iBio, Inc., and Icon Genetics- GmbH.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future type up-gradation, market expansion, and marketing tactics.
  • The global plant-based vaccines market report caters to various stakeholders in this industry including investors, researchers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global plant-based vaccines market.

Detailed Segmentation:

  • Global Plant-based Vaccines Market, By Vaccine Type:
    • Bacterial Vaccines
    • Viral Vaccines
    • Parasite Vaccines
    • Others Vaccines
  • Global Plant-based Vaccines Market, By Source:
    • Tobacco Plant
    • Maize
    • Potato
    • Others Sources
  • Global Plant-based Vaccines Market, By Application:
    • Influenza
    • Zika Virus Disease
    • Ebola Virus Disease
    • Poultry Diseases
    • Others Applications
  • Global Plant-based Vaccines Market, By Geography:
    • U.S.
      • By Vaccine Type:
      • Bacterial Vaccines
      • Viral Vaccines
      • Parasite Vaccines
      • Others Vaccines
      • By Source:
      • Tobacco Plant
      • Maize
      • Potato
      • Others Sources
      • By Application:
      • Influenza
      • Zika Virus Disease
      • Ebola Virus Disease
      • Poultry Diseases
      • Others Applications
    • Canada
      • By Vaccine Type:
      • Bacterial Vaccines
      • Viral Vaccines
      • Parasite Vaccines
      • Others Vaccines
      • By Source:
      • Tobacco Plant
      • Maize
      • Potato
      • Others Sources
      • By Application:
      • Influenza
      • Zika Virus Disease
      • Ebola Virus Disease
      • Poultry Diseases
      • Others Applications
    • Europe
      • By Vaccine Type:
      • Bacterial Vaccines
      • Viral Vaccines
      • Parasite Vaccines
      • Others Vaccines
      • By Source:
      • Tobacco Plant
      • Maize
      • Potato
      • Others Sources
      • By Application:
      • Influenza
      • Zika Virus Disease
      • Ebola Virus Disease
      • Poultry Diseases
      • Others Applications
    • Latin America
      • Regional Trends
    • Asia Pacific
      • Regional Trends
    • Middle East
      • Regional Trends
    • Africa
      • Regional Trends
  • Company Profiles
    • Medicago, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments
      • Key Strategies
    • iBio, Inc.
    • Icon Genetics- GmbH

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Vaccine Type
    • Market Snippet, By Source
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Epidemiology
  • Technologies Involved in Plant-based Vaccines Production
  • Plant-based Vaccine Production: Scenario
  • Plant-derived Pharmaceuticals in Clinical Trials
  • Government Initiatives
  • Regulatory Scenario

4. Global Plant-based Vaccines Market, By Vaccine Type, 2020 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2026 (%)
    • Y-o-Y Growth Analysis, 2021 - 2026
    • Segment Trends
  • Bacterial Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Viral Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Parasite Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)

5. Global Plant-based Vaccines Market, By Source, 2020 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2026 (%)
    • Y-o-Y Growth Analysis, 2021 - 2026
    • Segment Trends
  • Tobacco Plant
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Maize
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Potato
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)

6. Global Plant-based Vaccines Market, By Application, 2020 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2026 (%)
    • Y-o-Y Growth Analysis, 2021 - 2026
    • Segment Trends
  • Influenza
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Zika Virus Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Ebola Virus Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Poultry Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)

7. Global Plant-based Vaccines Market, By Region, 2020 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2021 - 2026
  • U.S.
    • Market Size and Forecast, By Vaccine Type, 2020 - 2026, (US$ Million)
    • Market Size and Forecast, By Source, 2020 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2020 - 2026, (US$ Million)
  • Canada
    • Market Size and Forecast, By Vaccine Type, 2020 - 2026, (US$ Million)
    • Market Size and Forecast, By Source, 2020 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2020 - 2026, (US$ Million)
  • Europe
    • Market Size and Forecast, By Vaccine Type, 2020 - 2026, (US$ Million)
    • Market Size and Forecast, By Source, 2020 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2020 - 2026, (US$ Million)
  • Latin America
    • Regional Trends
  • Asia Pacific
    • Regional Trends
  • Middle East
    • Regional Trends
  • Africa
    • Regional Trends

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Medicago, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • iBio, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Icon Genetics- GmbH
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies

9. Analyst Views

10. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top